Elicio Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Elicio Therapeutics, Inc. (ELTX) reported Foreign Currency Transaction Gain (Loss), before Tax of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-13
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $1.00K.
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $13.00K.
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $0.00.
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was $151.00K, a 25.98% decline from fiscal 2023.
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was $204.00K.
- Elicio Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-13 | $14.00K 10-Q · filed 2026-08-13 | $14.00K derived: sum of 3 quarters · filed 2026-08-13 | $14.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $13.00K 10-Q · filed 2026-05-11 | $13.00K derived: sum of 2 quarters · filed 2026-05-11 | $13.00K derived: sum of 3 quarters · filed 2026-05-11 | $13.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-13 | $8.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $8.00K derived: sum of 3 quarters · filed 2026-08-13 | $7.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $8.00K derived: sum of 2 quarters · filed 2026-05-11 | $7.00K derived: sum of 3 quarters · filed 2026-05-11 | -$2.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $7.00K derived: sum of 2 quarters · filed 2026-03-12 | -$2.00K derived: sum of 3 quarters · filed 2026-03-12 | $151.00K 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$1.00K 10-Q · filed 2025-11-13 | -$10.00K derived: sum of 2 quarters · filed 2025-11-13 | $143.00K 10-Q · filed 2025-11-13 | $392.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$9.00K 10-Q · filed 2025-08-07 | $144.00K 10-Q · filed 2025-08-07 | $393.00K derived: sum of 3 quarters · filed 2025-08-07 | $360.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $153.00K 10-Q · filed 2025-05-13 | $402.00K derived: sum of 2 quarters · filed 2025-05-13 | $369.00K derived: sum of 3 quarters · filed 2025-05-13 | $360.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $216.00K derived: sum of 2 quarters · filed 2025-03-31 | $207.00K derived: sum of 3 quarters · filed 2025-03-31 | $204.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$33.00K 10-Q · filed 2024-11-13 | -$42.00K derived: sum of 2 quarters · filed 2024-11-13 | -$45.00K 10-Q · filed 2024-11-13 | -$42.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$9.00K 10-Q · filed 2024-08-13 | -$9.00K 10-Q · filed 2024-08-13 | -$9.00K derived: sum of 3 quarters · filed 2024-08-13 | -$9.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | -$87.00K 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-05-15 | $0.00 derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $0.00 derived: sum of 3 quarters · filed 2024-03-29 | $0.00 10-K · filed 2024-03-29 | -$237.00K 10-K · filed 2023-03-17 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | -$215.00K 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | -$441.00K 10-Q · filed 2022-11-14 | $145.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | -$337.00K 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2023-08-14 | -$226.00K 10-Q · filed 2022-08-15 | $145.00K derived: sum of 3 quarters · filed 2023-08-14 | -$59.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $111.00K 10-Q · filed 2023-05-10 | $145.00K derived: sum of 2 quarters · filed 2023-05-10 | -$59.00K derived: sum of 3 quarters · filed 2023-05-10 | -$81.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | -$170.00K derived: sum of 2 quarters · filed 2023-03-17 | -$192.00K derived: sum of 3 quarters · filed 2023-03-17 | -$245.00K 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | -$204.00K 10-Q · filed 2022-11-14 | -$226.00K derived: sum of 2 quarters · filed 2022-11-14 | -$279.00K 10-Q · filed 2022-11-14 | $45.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$22.00K 10-Q · filed 2022-08-15 | -$75.00K 10-Q · filed 2022-08-15 | $249.00K derived: sum of 3 quarters · filed 2022-08-15 | $587.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$53.00K 10-Q · filed 2022-05-16 | $271.00K derived: sum of 2 quarters · filed 2022-05-16 | $609.00K derived: sum of 3 quarters · filed 2022-05-16 | $370.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $662.00K derived: sum of 2 quarters · filed 2022-03-30 | $423.00K derived: sum of 3 quarters · filed 2022-03-30 | $668.00K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $338.00K 10-Q · filed 2021-11-12 | $99.00K derived: sum of 2 quarters · filed 2021-11-12 | $344.00K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$239.00K 10-Q · filed 2021-08-12 | $6.00K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $245.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |